When PARP Inhibitors Fail in Ovarian Cancer
At the Colorado Center for Gynecologic Oncology, we are are keenly interested in new studies that can benefit our patients. Read below for more information on a study on PARB inhibitors in ovarian cancer. Study identifies subgroup for whom another go could be worthwhile Lack of response to a PARP inhibitor in epithelial ovarian cancer…
Details